Jasper Therapeutics, Inc. Restricted Cash, Noncurrent
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2026-08-14
- 2026-03-31: Restricted Cash, Noncurrent $417.00K.
- 2025-12-31: Restricted Cash, Noncurrent $417.00K.
- 2025-09-30: Restricted Cash, Noncurrent $417.00K.
- 2025-06-30: Restricted Cash, Noncurrent $417.00K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2026-03-31 | $417.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $417.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $417.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $417.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $417.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $417.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $417.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $417.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $417.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $417.00K 10-K · filed 2025-02-28 |
| 2023-09-30 | $417.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $417.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $417.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $417.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $417.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $417.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $417.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $345.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | $345.00K 10-Q · filed 2021-11-12 |
| 2020-12-31 | $345.00K 10-K · filed 2022-03-18 |